Middle East Pharmaceutical Industries Company Registered Shs Aktie
| 119,70SAR | -0,10SAR | -0,08% |
WKN DE: A40NLQ / ISIN: SA160G51UO10
Middle East Pharmaceutical Industries Company Registered Shs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Middle East Pharmaceutical Industries Company Registered Shs | Quartalszahlen | 30.03.2026 |
| Middle East Pharmaceutical Industries Company Registered Shs | Quartalszahlen | 18.05.2026 |
| Middle East Pharmaceutical Industries Company Registered Shs | Quartalszahlen | 10.08.2026 |
| Middle East Pharmaceutical Industries Company Registered Shs | Quartalszahlen | 05.11.2026 |
Middle East Pharmaceutical Industries Company Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2025 Earnings Release | 05.11.2025 |
| Quartalszahlen | Q2 2025 Earnings Release | 10.08.2025 |
| Quartalszahlen | Q1 2025 Earnings Release | 12.05.2025 |
| Quartalszahlen | Q4 2024 Earnings Release | 23.03.2025 |
| Quartalszahlen | Q3 2024 Earnings Release | 07.11.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 05.08.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 19.05.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 25.03.2024 |
Nachrichten zu Middle East Pharmaceutical Industries Company Registered Shs
| Keine Nachrichten verfügbar. |